Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.

2.

Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials

3.

Mezigdomide Combinations Show Promise in Multiple Myeloma

4.

The risk of cancer is decreased by following international health recommendations.

5.

a cutting-edge cancer diagnostic tool.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot